145 related articles for article (PubMed ID: 36734909)
1. Dose-dependent Effects of PRC2 and HDAC Inhibitors on Cardiomyocyte Hypertrophy Induced by Phenylephrine.
Zhao Z; Lv J; Guo N; Guo Q; Zeng S; Fang Y; Chen W; Wang Z
Curr Drug Targets; 2023; 24(4):371-378. PubMed ID: 36734909
[TBL] [Abstract][Full Text] [Related]
2. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
4. Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy.
Kee HJ; Kook H
J Mol Cell Cardiol; 2009 Dec; 47(6):770-80. PubMed ID: 19729022
[TBL] [Abstract][Full Text] [Related]
5. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.
Kong Y; Tannous P; Lu G; Berenji K; Rothermel BA; Olson EN; Hill JA
Circulation; 2006 Jun; 113(22):2579-88. PubMed ID: 16735673
[TBL] [Abstract][Full Text] [Related]
6. A traditional Chinese medicine, Lujiao prescription, as a potential therapy for hypertrophic cardiomyocytes by acting on histone acetylation.
Zhao W; Hu W; Wang X; Xia N; Hu Q; Zhou H
J Chin Med Assoc; 2015 Aug; 78(8):486-93. PubMed ID: 25913212
[TBL] [Abstract][Full Text] [Related]
7. Interactions between the ERK1/2 signaling pathway and PCAF play a key role in PE‑induced cardiomyocyte hypertrophy.
Mao Q; Wu S; Peng C; Peng B; Luo X; Huang L; Zhang H
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278478
[TBL] [Abstract][Full Text] [Related]
8. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
9. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.
Sunagawa Y; Shimizu K; Katayama A; Funamoto M; Shimizu K; Nurmila S; Shimizu S; Miyazaki Y; Katanasaka Y; Hasegawa K; Morimoto T
J Pharmacol Sci; 2021 Oct; 147(2):169-175. PubMed ID: 34384564
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy.
Cao DJ; Wang ZV; Battiprolu PK; Jiang N; Morales CR; Kong Y; Rothermel BA; Gillette TG; Hill JA
Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4123-8. PubMed ID: 21367693
[TBL] [Abstract][Full Text] [Related]
11. JNK signaling-dependent regulation of histone acetylation are involved in anacardic acid alleviates cardiomyocyte hypertrophy induced by phenylephrine.
Peng B; Peng C; Luo X; Wu S; Mao Q; Zhang H; Han X
PLoS One; 2021; 16(12):e0261388. PubMed ID: 34914791
[TBL] [Abstract][Full Text] [Related]
12. [Effect of miRNA-199a on rat cardiac hypertrophy].
Xu XD; Song XW; Jing Q; Qin YW
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 May; 39(5):446-50. PubMed ID: 21781601
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II induces cardiomyocyte hypertrophy probably through histone deacetylases.
Lu Y; Yang S
Tohoku J Exp Med; 2009 Sep; 219(1):17-23. PubMed ID: 19713680
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA
Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565
[TBL] [Abstract][Full Text] [Related]
15. Myofibril growth during cardiac hypertrophy is regulated through dual phosphorylation and acetylation of the actin capping protein CapZ.
Lin YH; Warren CM; Li J; McKinsey TA; Russell B
Cell Signal; 2016 Aug; 28(8):1015-24. PubMed ID: 27185186
[TBL] [Abstract][Full Text] [Related]
16. CaMKIIδ meditates phenylephrine induced cardiomyocyte hypertrophy through store-operated Ca
Ji Y; Guo X; Zhang Z; Huang Z; Zhu J; Chen QH; Gui L
Cardiovasc Pathol; 2017; 27():9-17. PubMed ID: 27940402
[TBL] [Abstract][Full Text] [Related]
17. Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size.
Zhou Y; Jiang Y; Kang YJ
J Mol Cell Cardiol; 2008 Jul; 45(1):106-17. PubMed ID: 18495151
[TBL] [Abstract][Full Text] [Related]
18. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
[TBL] [Abstract][Full Text] [Related]
19. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro.
Autelitano DJ; Ridings R; Tang F
Cardiovasc Res; 2001 Aug; 51(2):255-64. PubMed ID: 11470465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
